| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/22/2009 | WO2008155389A3 Dms in foaming creams |
| 05/22/2009 | WO2008147715A3 Multi-dose concentrate esmolol with benzyl alcohol |
| 05/22/2009 | WO2008082966A3 Radiopharmaceutical administration methods, fluid delivery systems and components thereof |
| 05/22/2009 | WO2008076287A3 Methods of making pharmaceutical components for customized drug products |
| 05/22/2009 | WO2007044437A3 Octanol formulations and methods of treatment using the same |
| 05/22/2009 | WO2007019463A3 Methods of delivering therapeutics to the brain |
| 05/22/2009 | WO2006127962A3 Particulate formulations for intradermal delivery of biologically active agents |
| 05/22/2009 | CA2705733A1 Reduced dose intravenous acetaminophen |
| 05/22/2009 | CA2705724A1 Process for manufacturing chewable dosage forms for drug delivery and products thereof |
| 05/22/2009 | CA2705520A1 Viscous terpolymers as drug delivery platform |
| 05/22/2009 | CA2705518A1 Water dispersible enteric coating formulation for nutraceutical and pharmaceutical dosage forms |
| 05/22/2009 | CA2705031A1 Gel-stabilized liposome compositions, methods for their preparation and uses thereof |
| 05/22/2009 | CA2704949A1 Gastrointestinal delivery systems |
| 05/22/2009 | CA2704510A1 Solid compositions |
| 05/22/2009 | CA2704258A1 Novel thermosensitive liposomes containing therapeutic agents |
| 05/22/2009 | CA2703008A1 Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener |
| 05/22/2009 | CA2700444A1 Pharmaceutical compositions |
| 05/21/2009 | US20090131919 Implantable medical device |
| 05/21/2009 | US20090131918 Device and method for the controlled release of a predefined quantity of a substance |
| 05/21/2009 | US20090131905 Microneedle devices and methods of manufacture and use thereof |
| 05/21/2009 | US20090131898 Absorbent foam material, a method of producing it and an absorbent structure containing said foam material |
| 05/21/2009 | US20090131882 Medical device for delivering patches |
| 05/21/2009 | US20090131851 Filter assembly with microfabricated filter element |
| 05/21/2009 | US20090131641 Method for assembling subunits into capsoids |
| 05/21/2009 | US20090131639 Antibody-containing solution formulations |
| 05/21/2009 | US20090131542 Emulsifier Combination, Emulsion Containing the Emulsifier Combination, and a Process for its Production |
| 05/21/2009 | US20090131514 Buccal, polar and non-polar sprays containing propofol |
| 05/21/2009 | US20090131387 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/21/2009 | US20090130444 calcium phosphates in granular form having an X-ray diffraction pattern characteristic of hydroxyapatite in which a portion of the anions of the crystal structure are substituted with carbonate anions ( Ca10(PO4)6(OH)2-2x(CO3)x, X= 0 or 1); good compressibility and flow properties; used as excipient |
| 05/21/2009 | US20090130287 Microcrystalline Cellulose Compositions |
| 05/21/2009 | US20090130269 Formation of sugar coatings |
| 05/21/2009 | US20090130234 Composition for the Treatment of Diabetic Periodontitis |
| 05/21/2009 | US20090130217 Cosmetic Composition Containing Nanoparticulate a-Alumina |
| 05/21/2009 | US20090130216 Multimodal particulate formulations |
| 05/21/2009 | US20090130215 Granular preparation containing biguanide compound |
| 05/21/2009 | US20090130214 Gemcitabine derivatives nanoparticles |
| 05/21/2009 | US20090130213 Rapidly disintegrating solid oral dosage form |
| 05/21/2009 | US20090130212 Composition and improved method for preparation of small particles |
| 05/21/2009 | US20090130211 Gelled colloidal emulsion for appetite suppression |
| 05/21/2009 | US20090130210 Pharmaceutical compositions of sirolimus |
| 05/21/2009 | US20090130209 Novel Pyridazinone Derivatives |
| 05/21/2009 | US20090130208 Modified release niacin formulations |
| 05/21/2009 | US20090130207 Pharmaceutical Tablets Having a Relatively Inactive Segment |
| 05/21/2009 | US20090130206 Controlled Release Compositions of an Antidepressant Agent |
| 05/21/2009 | US20090130205 Solid Pharmaceutical Composition Comprising Donepezil Hydrochloride |
| 05/21/2009 | US20090130204 Dosage Form Comprising Therapeutic Formulation |
| 05/21/2009 | US20090130203 Extracts of chenopodium ambrosioides l., the compositions comprising said extracts, the preparing process and application thereof |
| 05/21/2009 | US20090130202 Pharmaceutical Compositions |
| 05/21/2009 | US20090130201 polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
| 05/21/2009 | US20090130200 Granules for controlled release of tamsulosin |
| 05/21/2009 | US20090130199 Preparations, Methods And Kits Useful For The Treatment of Cough |
| 05/21/2009 | US20090130198 Pharmaceutical composition with enhanced bioavailability |
| 05/21/2009 | US20090130197 Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt |
| 05/21/2009 | US20090130196 Bacteriophage composition |
| 05/21/2009 | US20090130195 Prostate carcinogenesis predictor |
| 05/21/2009 | US20090130194 Methods of Treating Cancer with High Potency Lipid-Based Platinum Compound Formulations Administered Intravenously |
| 05/21/2009 | US20090130193 Methods of Treating Cancer with High Potency Lipid-Based Platinum Compound Formulations Administered Intraperitoneally |
| 05/21/2009 | US20090130192 Class iii slrp agonists for the reduction of blood vessel formation |
| 05/21/2009 | US20090130191 Osteoclast Growth Inhibitor, Oral Composition, and Preventive or Therapeutic Agent for Bone Diseases, Containing Liposome-Encapsulated Lactoferrin |
| 05/21/2009 | US20090130190 Transdermal System for the Delivery of Sufentanil and Its Analogs |
| 05/21/2009 | US20090130189 Means for transdermal administration of nicotine |
| 05/21/2009 | US20090130185 Anti-Microbial Compositions Comprising a Cationic Peptide and a Glycylglycine Endopeptidase |
| 05/21/2009 | US20090130184 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
| 05/21/2009 | US20090130183 Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol |
| 05/21/2009 | US20090130182 Topical compositions for treating pain |
| 05/21/2009 | US20090130181 Antibacterial Surface Treatments Based on Silver Cluster Deposition |
| 05/21/2009 | US20090130180 Preparation for External Use |
| 05/21/2009 | US20090130179 Confectionery compositions including markings for delivery of actives |
| 05/21/2009 | US20090130178 Formulation for decreasing tobacco, alcohol, drug or food consumption |
| 05/21/2009 | US20090130176 Intraocular lens with drug delivery system attached thereto |
| 05/21/2009 | US20090130173 Bone matrix compositions and methods |
| 05/21/2009 | US20090130169 Sterilizing compositions comprising phosphors for converting electromagnetic radiation to uvc radiation and methods for using the same |
| 05/21/2009 | US20090130164 Method to control cell adhesion and growth on biopolymer surfaces |
| 05/21/2009 | US20090130163 Drugs With Improved Hydrophobicity For Incorporation in Medical Devices |
| 05/21/2009 | US20090130160 Fiber for wound dressing |
| 05/21/2009 | US20090130153 Emulsifier Combination, Emulsion Containing the Emulsifier Combination, and a Process for its Production |
| 05/21/2009 | US20090130150 Biologically Active Nanoparticles A Carbonate-Substituted Hydroxyapatite, Process For Their Preparation And Compositions Incorporating The Same |
| 05/21/2009 | US20090130145 Vaccine |
| 05/21/2009 | US20090130126 Dna expression vectors |
| 05/21/2009 | US20090130080 Reducing blood glucose level in a non-obese or obese human afflicted with Type 2 diabetes by administering purified human placental alkaline phosphatase |
| 05/21/2009 | US20090130029 Glycerol ethers vehicle and pharmaceutical compositions thereof |
| 05/21/2009 | US20090130027 Compositions and methods for treating purpura |
| 05/21/2009 | US20090130026 Pharmaceutical solution formulations for pressurised metered dose inhalers |
| 05/21/2009 | US20090130022 Mri contrast medium containing liposomes |
| 05/21/2009 | US20090130021 Methods, products and uses involving platelets and/or the vasculature |
| 05/21/2009 | US20090127112 Biologically active metal-coated proteins |
| 05/21/2009 | US20090126732 Dry powder inhalation system for transpulmonary administration |
| 05/21/2009 | US20090126644 Fragrance composition |
| 05/21/2009 | CA2644179A1 Novel pharmaceutical composition comprising a disintegration matrix |
| 05/20/2009 | EP2060573A2 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as medicine |
| 05/20/2009 | EP2060300A1 C-19 steroids for therapeutic uses |
| 05/20/2009 | EP2060271A1 Liposome and immunostimulating composition comprising the same |
| 05/20/2009 | EP2060264A1 Agent for treating eye diseases |
| 05/20/2009 | EP2060259A1 Medical compositions for intravesical treatment of bladder cancer |
| 05/20/2009 | EP2060253A1 Pharmaceutical forms for the release of active compounds |
| 05/20/2009 | EP2060252A1 New formulation of galactosylceramide derivatives |
| 05/20/2009 | EP2060183A2 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 05/20/2009 | EP2059558A2 Novel nanoparticles |
| 05/20/2009 | EP2059496A1 Acetylenic compounds |
| 05/20/2009 | EP2059331A1 Adsorption and release of nitric oxide in metal organic frameworks |